Jin Bae Lee

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial

Joo‐Yong Hahn, Young Bin Song, Ju Hyeon Oh et al. · The Lancet · 2018 · 352 citations

Percutaneous Coronary Intervention, Thrombosis, Cardiovascular Disease +9

Fractional Flow Reserve and Cardiac Events in Coronary Artery Disease

Jung‐Min Ahn, Duk‐Woo Park, Eun‐Seok Shin et al. · Circulation · 2017 · 176 citations · Full text

Optical coherence tomography-guided versus angiography-guided percutaneous coronary intervention for patients with complex lesions (OCCUPI): an investigator-initiated, multicentre, randomised, open-label, superiority trial in South Korea

Sung-Jin Hong, Seung‐Jun Lee, Sang Hyup Lee et al. · The Lancet · 2024 · 63 citations

Percutaneous Coronary Intervention, Superiority Trial, Health Sciences +13